Moreover ApoE−/− mice with a heterozygous deletion of the IR and its downstream target, Insulin Receptor Substrate 1 (IRS1), also develop accelerated atherosclerosis [4], as well as mice lacking insulin receptor substrate 2 (IRS2−/−) [5]. Here, IRS1 is linked to atherosclerosis.